4.7 Article

Barriers to Surveillance for Hepatocellular Carcinoma in a Multicenter Cohort

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Editorial Material Gastroenterology & Hepatology

Racial and Ethnic Disparities in Barriers to Care in Patients with Hepatocellular Carcinoma

Haley Schoenberger et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Review Gastroenterology & Hepatology

Conceptual Model for the Hepatocellular Carcinoma Screening Continuum: Current Status and Research Agenda

Amit G. Singal et al.

Summary: Hepatocellular carcinoma (HCC) has a poor prognosis with survival rates below 20% in 5 years, partly due to failures in the cancer screening process continuum. A conceptual model outlining discrete steps in the HCC screening process highlights delays or failures at each step and identifies factors contributing to these failures at the patient, provider, and health care system levels. Comparing HCC screening processes with breast and colorectal cancer screening can help identify opportunities for improvement and ultimately improve early detection of HCC.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Review Gastroenterology & Hepatology

Incidence of Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-analysis, and Meta-regression

Lorenzo A. Orci et al.

Summary: Nonalcoholic fatty liver disease (NAFLD) may be a risk factor for hepatocellular carcinoma (HCC), and this study used meta-analysis to analyze the incidence rates of HCC in NAFLD patients. The results showed that NAFLD patients with cirrhosis have a similar risk of developing HCC compared to cirrhosis patients with other causes. However, the incidence of HCC in nonalcoholic steatohepatitis or simple steatosis patients is lower.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis

Amit G. Singal et al.

Summary: In this systematic review and meta-analysis, HCC surveillance was found to be associated with improved early-stage detection, curative treatment receipt, and survival in patients with cirrhosis. However, there was significant heterogeneity in the pooled estimates, and there were fewer data quantifying potential surveillance-related harms. Available data suggest that HCC surveillance is of high value in patients with cirrhosis, although further studies evaluating benefits and harms are still needed.

JOURNAL OF HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Patient Preferences for Hepatocellular Carcinoma Surveillance Parameters

Sean A. Woolen et al.

Summary: This study assessed patients with cirrhosis' preferences for HCC surveillance modalities, finding that patients prioritize benefits of surveillance over potential harms or inconveniences. Patients showed a preference for abbreviated MRI, MRI, or blood-based biomarkers over traditional ultrasound or ultrasound with AFP.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Novel Application of Predictive Modeling: A Tailored Approach to Promoting HCC Surveillance in Patients With Cirrhosis

Amit G. Singal et al.

Summary: This study found that predictive models can be used to determine the likelihood of patients responding to surveillance programs, thus enabling tailored interventions to improve the effectiveness and cost-effectiveness of hepatocellular carcinoma (HCC) surveillance.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

Patient-Reported Barriers Are Associated With Receipt of Hepatocellular Carcinoma Surveillance in a Multicenter Cohort of Patients With Cirrhosis

Amit G. Singal et al.

Summary: The study found that patient-reported barriers such as knowledge deficits, costs, difficulty scheduling, and transportation significantly impact less frequent receipt of HCC surveillance. This indicates a need for patient-centered interventions, such as patient navigation.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Oncology

Diagnostic and Therapeutic Delays in Patients With Hepatocellular Carcinoma

Ashwin Rao et al.

Summary: Delays in diagnosis and treatment are common in patients with HCC, but treatment delays do not seem to significantly impact overall survival.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)

Article Oncology

Biomarkers for the Early Detection of Hepatocellular Carcinoma

Neehar D. Parikh et al.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)

Article Gastroenterology & Hepatology

Cost-Effectiveness of Hepatocellular Carcinoma Surveillance: An Assessment of Benefits and Harms

Neehar D. Parikh et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)

Article Gastroenterology & Hepatology

Risk of hepatocellular carcinoma in Danish outpatients with alcohol-related cirrhosis

Peter Jepsen et al.

JOURNAL OF HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Racial and Ethnic Differences in Presentation and Outcomes of Hepatocellular Carcinoma

Nicole E. Rich et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)

Article Gastroenterology & Hepatology

Design of the Texas Hepatocellular Carcinoma Consortium Cohort Study

Ziding Feng et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2019)

Article Gastroenterology & Hepatology

Adherence to colorectal cancer screening measured as the proportion of time covered

Caitlin C. Murphy et al.

GASTROINTESTINAL ENDOSCOPY (2018)

Article Gastroenterology & Hepatology

Untitled

LIVER INTERNATIONAL (2018)

Article Medicine, General & Internal

Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study

Elliot B Tapper et al.

BMJ-British Medical Journal (2018)

Article Medicine, General & Internal

Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study

Elliot B Tapper et al.

BMJ-British Medical Journal (2018)

Article Gastroenterology & Hepatology

Untitled

HEPATOLOGY (2017)

Article Gastroenterology & Hepatology

Cirrhosis is under-recognised in patients subsequently diagnosed with hepatocellular cancer

M. Walker et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)

Article Gastroenterology & Hepatology

Improved Surveillance for Hepatocellular Carcinoma With a Primary Care-Oriented Clinical Reminder

Lauren A. Beste et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)

Editorial Material Oncology

Unifying Screening Processes Within the PROSPR Consortium: A Conceptual Model for Breast, Cervical, and Colorectal Cancer Screening

Elisabeth F. Beaber et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

Editorial Material Oncology

Unifying Screening Processes Within the PROSPR Consortium: A Conceptual Model for Breast, Cervical, and Colorectal Cancer Screening

Elisabeth F. Beaber et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)

Review Medicine, General & Internal

Screening for Hepatocellular Carcinoma in Chronic Liver Disease A Systematic Review

Devan Kansagara et al.

ANNALS OF INTERNAL MEDICINE (2014)

Article Oncology

Screening Process Failures for Hepatocellular Carcinoma

Amit G. Singal et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2014)

Article Oncology

Failure Rates in the Hepatocellular Carcinoma Surveillance Process

Amit G. Singal et al.

CANCER PREVENTION RESEARCH (2012)

Review Health Care Sciences & Services

Utilization of Hepatocellular Carcinoma Surveillance Among American Patients: A Systematic Review

Amit G. Singal et al.

JOURNAL OF GENERAL INTERNAL MEDICINE (2012)

Article Oncology

Randomized controlled trial of screening for hepatocellular carcinoma

BH Zhang et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)